Vaccine Development
portes grátis
Vaccine Development
From Concept to Clinic
Prasad, A Krishna
Royal Society of Chemistry
11/2022
322
Dura
Inglês
9781788018777
15 a 20 dias
Descrição não disponível.
Vaccine Development: From Concept to Clinic;
Pre-clinical Safety Assessment Considerations for Vaccine Development;
Clinical Trials in the Development of Vaccines for Infectious Diseases;
Clinical Trials in Immunotherapeutic Vaccine Development;
Pathogenesis and Immunity of SARS-CoV-2 and Vaccination Programs against COVID-19;
High Throughput Assays for Clinical Development;
Virus-like Particle Based Vaccines: GARDASIL (R);
Cell Culture-based Influenza Vaccine Development;
Conjugate Vaccines: Design and Development Considerations;
Vaccine Adjuvants: Mechanisms of Action;
Development Considerations for Final Dosage Forms: Mucosal Bacterial Vaccines;
Exploiting Glycans in Vaccine Design;
The PATH Experience in Vaccine Development Partnerships with Manufacturers from Emerging Markets
Pre-clinical Safety Assessment Considerations for Vaccine Development;
Clinical Trials in the Development of Vaccines for Infectious Diseases;
Clinical Trials in Immunotherapeutic Vaccine Development;
Pathogenesis and Immunity of SARS-CoV-2 and Vaccination Programs against COVID-19;
High Throughput Assays for Clinical Development;
Virus-like Particle Based Vaccines: GARDASIL (R);
Cell Culture-based Influenza Vaccine Development;
Conjugate Vaccines: Design and Development Considerations;
Vaccine Adjuvants: Mechanisms of Action;
Development Considerations for Final Dosage Forms: Mucosal Bacterial Vaccines;
Exploiting Glycans in Vaccine Design;
The PATH Experience in Vaccine Development Partnerships with Manufacturers from Emerging Markets
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Pharmacology; Pharmaceuticals; Organic Chemistry
Vaccine Development: From Concept to Clinic;
Pre-clinical Safety Assessment Considerations for Vaccine Development;
Clinical Trials in the Development of Vaccines for Infectious Diseases;
Clinical Trials in Immunotherapeutic Vaccine Development;
Pathogenesis and Immunity of SARS-CoV-2 and Vaccination Programs against COVID-19;
High Throughput Assays for Clinical Development;
Virus-like Particle Based Vaccines: GARDASIL (R);
Cell Culture-based Influenza Vaccine Development;
Conjugate Vaccines: Design and Development Considerations;
Vaccine Adjuvants: Mechanisms of Action;
Development Considerations for Final Dosage Forms: Mucosal Bacterial Vaccines;
Exploiting Glycans in Vaccine Design;
The PATH Experience in Vaccine Development Partnerships with Manufacturers from Emerging Markets
Pre-clinical Safety Assessment Considerations for Vaccine Development;
Clinical Trials in the Development of Vaccines for Infectious Diseases;
Clinical Trials in Immunotherapeutic Vaccine Development;
Pathogenesis and Immunity of SARS-CoV-2 and Vaccination Programs against COVID-19;
High Throughput Assays for Clinical Development;
Virus-like Particle Based Vaccines: GARDASIL (R);
Cell Culture-based Influenza Vaccine Development;
Conjugate Vaccines: Design and Development Considerations;
Vaccine Adjuvants: Mechanisms of Action;
Development Considerations for Final Dosage Forms: Mucosal Bacterial Vaccines;
Exploiting Glycans in Vaccine Design;
The PATH Experience in Vaccine Development Partnerships with Manufacturers from Emerging Markets
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
